FinTechFunding

Tissue Repair: Receives second US patent for Glucoprime

Tissue Repair Receives second US patent for Glucoprime

  • Tissue Repair (TRP) receives a second US patent for its topical skin treatment active ingredient, Glucoprime
  • Glucoprime is an active pharmaceutical ingredient (API) used to treat skin conditions like burns, pressure ulcers and post-procedure wounds whether it be surgical or cosmetic
  • This latest patent grants TissueRepair with exclusive rights to use Glucoprime as a topical application to treat a large number of skin conditions
  • It follows TRP’s first patent approval in April 2022 which granted the company exclusive rights to the method of manufacturing
  • TRP shares are up 6.45 per cent to close at 33 cents
Previous article
Cooper Metals: Completes RC drill program at King Solomon, northwest QLD
Next article
Green Technology Metals: Begins phase one drilling at Root, Ontario
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

NYSE Parent Invests $600M in Polymarket, Strengthening Market Position

This significant investment signals confidence in the future of predictive markets.Highlights: NYSE's parent company allocates $600M to Polymarket.Investment...
FinTech

Nexi Expands SEPA Direct Debit with Danish Banks, Enhancing Payments Integration

Nexi's collaboration with Danish banks aims to strengthen payment services across Europe.Highlights: Nexi partners with several Danish banks...
FinTech

Lloyds Confirms App Glitch Exposed Data of Almost Half a Million Customers

The significant data breach prompts concerns over customer privacy.Highlights: Lloyds Banking Group admits to a data breach affecting...
FinTech

Mastercard Restricts Sale of Nets Payments Unit Purchased for $3.2 Billion

Mastercard looks to divest its Nets payments segment as part of strategic realignment.Highlights: Mastercard is seeking to sell...